Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

NCT03551730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

COMBINATION_PRODUCT: PRT064445/Enoxaparin
COMBINATION_PRODUCT: Placebo/Enoxaparin
DRUG: Placebo

Sponsor

Portola Pharmaceuticals